4-(6-nitro-4-oxo-4H-benzo[e][1,3]thiazin-2-yl)-N-phenylpiperazine-1-carbothioamide

ID: ALA3884935

PubChem CID: 134131596

Max Phase: Preclinical

Molecular Formula: C19H17N5O3S2

Molecular Weight: 427.51

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=c1nc(N2CCN(C(=S)Nc3ccccc3)CC2)sc2ccc([N+](=O)[O-])cc12

Standard InChI:  InChI=1S/C19H17N5O3S2/c25-17-15-12-14(24(26)27)6-7-16(15)29-19(21-17)23-10-8-22(9-11-23)18(28)20-13-4-2-1-3-5-13/h1-7,12H,8-11H2,(H,20,28)

Standard InChI Key:  UTLILQNOKQDLCD-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
   30.0778   -4.7133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0767   -5.5328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7847   -5.9418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4944   -5.5323    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7829   -4.3044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4946   -4.7124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1998   -4.3024    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   32.1996   -3.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4880   -3.0747    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.7765   -3.4864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9083   -3.0742    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6165   -3.4838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3214   -3.0776    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3243   -2.2600    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.6161   -1.8504    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.9050   -2.2583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0670   -3.0809    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.0329   -1.8529    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.7397   -2.2631    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.0347   -1.0358    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   36.4483   -1.8560    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1554   -2.2703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8635   -1.8639    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.8657   -1.0458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.1539   -0.6359    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.4487   -1.0446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.3667   -5.9446    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   29.3661   -6.7618    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6594   -5.5354    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  1  1  0
  5  6  2  0
  5 10  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
  8 11  1  0
 10 17  2  0
 14 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 27 28  2  0
 27 29  1  0
  2 27  1  0
M  CHG  2  27   1  29  -1
M  END

Alternative Forms

  1. Parent:

    ALA3884935

    ---

Associated Targets(non-human)

gyrB DNA gyrase subunit A/DNA gyrase subunit B (505 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 427.51Molecular Weight (Monoisotopic): 427.0773AlogP: 3.08#Rotatable Bonds: 3
Polar Surface Area: 91.61Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.56CX LogD: 3.56
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.39Np Likeness Score: -2.26

References

1. Chaudhari K, Surana S, Jain P, Patel HM..  (2016)  Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.,  124  [PMID:27569197] [10.1016/j.ejmech.2016.08.034]
2. Dighe SN, Collet TA..  (2020)  Recent advances in DNA gyrase-targeted antimicrobial agents.,  199  [PMID:32460040] [10.1016/j.ejmech.2020.112326]

Source